Timothy Yarnell
About Timothy Yarnell
Timothy Yarnell is a Territory Manager at Novocure in St. Louis, Missouri, with extensive experience in the medical device and specialty pharmaceutical industries.
Current Role at Novocure
Timothy Yarnell currently serves as a Territory Manager at Novocure, based in St Louis, Missouri, United States. Since joining in June 2022, he has been contributing to Novocure's mission to extend survival in aggressive forms of cancer. His role heavily involves managing territories and driving sales, particularly focused on innovative therapies such as Tumor Treating Fields for glioblastoma and malignant pleural mesothelioma.
Previous Experience at Natera
Before his current position, Timothy Yarnell worked at Natera from 2020 to 2022. He initially held the role of Community Nephrologist Specialist for 9 months in the Greater St. Louis area. He then transitioned to Organ Health Specialist, a position he held for a year. In these roles, he specialized in diagnostic testing and played a key role in the company’s organ health division.
Long Tenure at Novo Nordisk
Timothy Yarnell has extensive experience from his time with Novo Nordisk, where he worked for a total of 12 years. From 2007 to 2010, he served as an Endocrinology Diabetes Care Specialist in the Greater St. Louis Area. He then held the role of Sr. Endocrinology Diabetes Care Specialist from 2011 to 2020 in the same region, including Southern Illinois. His responsibilities included managing diabetes care and building strong relationships within the endocrinology community.
Educational Background
Timothy Yarnell studied at Lindenwood University, where he achieved a Bachelor of Arts (B.A.) in Business Administration. His academic background in business administration has provided a strong foundation for his roles in medical device and specialty pharmaceutical industries, particularly in sales and territory management.
Specialized Experience in Oncology and Diagnostic Testing
With an extensive background in the medical device and specialty pharmaceutical industries, Timothy Yarnell has specialized experience in oncology and diagnostic testing. Over his career, he has been involved in clinical trials for various cancers including brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and gastric cancer. This deep involvement in oncology has enabled him to contribute significantly to commercializing innovative therapies at his current role in Novocure.